Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis R&D Portfolio Grows 44% Since 2000; Half Of Projects Are NMEs

Nov 24 2003

• By The Pink Sheet

Related Content

Pfizer Considering Biotech Acquisitions; “Probably No” Big Mergers

Nov 17 2003

Novartis Prexige Is “Not Approvable;” COX-2 Launch At Least Two Years Away

Sep 29 2003

Novartis E-Trial Program Will Help Reduce Clinical Trial Personnel By 25%

Oct 28 2002

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window